HALISTER: Gilead Must Pay Merck $200 Million for Hepatitis C Patents (1)

Gilead Must Pay Merck $200 Million for Hepatitis C Patents (1)

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
GILD US (Gilead Sciences Inc)
MRK US (Merck & Co Inc)

People
Beth Freeman ((US)Dist Court:CA-Northern)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283